AMANDA BOATRIGHT-SCRUGGS: Open Payments
NPI 1407159437 · ALMA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 43 payments from 12 companies in 2025. Trend: 2023 $470 · 2024 $660 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $326 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $181 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $141 |
| Novo Nordisk Inc | 2 | $136 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| Amgen Inc. | 4 | $88 |
| Corcept Therapeutics | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Esperion Therapeutics, Inc. | 2 | $28 |
Products named: CAPLYTA, BREZTRI, Kerendia, Wegovy, TRELEGY ELLIPTA, AIRSUPRA, OTEZLA, Korlym.
Industry payments across GA — which companies pay providers there.
